Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 8.94
-0.23 (-2.51%)
Jul 28, 2026, 4:08 PM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 9.49 billion as of July 28, 2026. Its market cap has decreased by -8.07% in one year.
Market Cap
9.49B
Enterprise Value
7.38B
Revenue
2.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.94
ChartMarket Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 9.49B, a decrease of -39.52%. That is a compound annual growth rate of -6.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 9.49B | -15.59% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenFleet Therapeutics (Shanghai) | 12.29B |
| Nanjing Leads Biolabs | 11.55B |
| HBM Holdings | 10.95B |
| Shaanxi Micot Pharmaceutical Technology | 10.48B |
| Suzhou Ribo Life Science | 9.13B |
| Everest Medicines | 8.86B |
| TenNor Therapeutics (Suzhou) | 8.75B |
| CARsgen Therapeutics Holdings | 8.43B |